Bibliography
- Kim SY, Wong AHM, Abou Neel EA, et al. The future perspectives of natural materials for pulmonary drug delivery and lung tissue engineering. Expert Opin Drug Deliv 2015;12(6):869-87
- Martin AR, Finlay WH. Nebulizers for drug delivery to the lungs. Expert Opin Drug Deliv 2015;12(6):889-900
- Ivey JW, Vehring R, Finlay WH. Understanding pressurized metered dose inhaler performance. Expert Opin Drug Deliv 2015;12(6):901-16
- Rashid J, Absar S, Nahar K, et al. Newer devices and improved formulations of inhaled insulin. Expert Opin Drug Deliv 2015;12(6):917-28
- Ali ME, McConville JT, Lamprecht A. Pulmonary delivery of anti-inflammatory agents. Expert Opin Drug Deliv 2015;12(6):929-45
- Muralidharan P, Hayes DJr, Mansour HM. Dry powder inhalers in COPD, lung inflammation and pulmonary infections. Expert Opin Drug Deliv 2015;12(6):947-62
- Mehta N, Aggarwal B, Gogtay J, Abdool-Gaffar S. Comparing the efficacy and safety of salmeterol/fluticasone pMDI versus its monocomponents, other LABA/ICS pMDIs and salmeterol/fluticasone Diskus in patients with asthma. Expert Opin Drug Deliv 2015;12(6):963-75
- Hong S-H, Park S-J, Lee S, et al. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy. Expert Opin Drug Deliv 2015;12(6):977-91
- Tulbah AS, Ong HX, Morgan L, et al. Dry powder formulation of simvastatin. Expert Opin Drug Deliv 2015;12(6):857-68
- Jia Y, Krishnan L, Omri A. Nasal and pulmonary vaccine delivery using particulate carriers. Expert Opin Drug Deliv 2015;12(6):993-1008
- Lee W-H, Loo C-Y, Traini D, Young PM. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opin Drug Deliv 2015;12(6):1009-26
- Respaud R, Vecellio L, Diot P, Heuze´ -Vourc’h N. Nebulization as a delivery method for mAbs in respiratory diseases. Expert Opin Drug Deliv 2015;12(6):1027-39